ロード中...
Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
Interstitial lung disease (ILD) is the primary cause of death in patients with systemic sclerosis (SSc). It is thought that chronic inflammation is a key component in SSc-ILD. Treatment, such as cyclophosphamide (CYC), targets this inflammation. We hypothesized that treatment with CYC might be more...
保存先:
| 出版年: | Clin Rheumatol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer London
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6154086/ https://ncbi.nlm.nih.gov/pubmed/29987427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-018-4171-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|